APM
DCPH

Avidity Partners Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Avidity Partners Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,126,000
Closed -$18.5M – 100
2022
Q4 		$18.5M Sell
1,126,000
-65,800
-6% -$1.07M 0.4% 53
2022
Q3 		$22M Sell
1,191,800
-8,200
-0.7% -$129K 0.45% 50
2022
Q2 		$15.8M Buy
+1,200,000
New +$13.2M 0.36% 43
2020
Q3 		– Sell
-156,266
Closed -$9.33M – 89
2020
Q2 		$9.33M Buy
+156,266
New +$8.36M 0.6% 46

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Avidity Partners Management's DCPH Position: Q1 2023 in Review

Avidity Partners Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2023, closing a stake of 1,126,000 shares — an estimated $18.5M sold.

Avidity Partners Management first reported a position in DCPH in Q2 2020 and held it in 4 quarters. The position peaked at $22M in Q3 2022. 146 funds tracked by Wall St. Rank hold DCPH as of Q1 2023.

  • Avidity Partners Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Avidity Partners Management sold 1,126,000 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $18.5M.
  • Avidity Partners Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 4 quarters.
  • Avidity Partners Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $22M in Q3 2022.
  • 146 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Avidity Partners Management's 13F filing for Q1 2023, filed 15 May 2023.